Genocea Biosciences CEO William Clark's 2018 pay slips 14% to $1.3M
Genocea Biosciences reports 2018 executive compensation
By ExecPay News
Published: March 29, 2019
Genocea Biosciences reported fiscal year 2018 executive compensation information on March 29, 2019.
In 2018, four executives at Genocea Biosciences received on average a compensation package of $770K, a 14% decrease compared to previous year.
William Clark, Chief Executive Officer, received $1.3M in total, which decreased by 14% compared to 2017. 45% of Clark's compensation, or $583K, was in option awards. Clark also received $207K in non-equity incentive plan, $515K in salary, as well as $6K in other compensation.
Jessica Baker Fletchner, Chief Scientific Officer, received a compensation package of $734K, which increased by 2% compared to previous year. 47% of the compensation package, or $346K, was in salary.
Eric Hoffman, Former Chief Business Officer, earned $546K in 2018, a 22% decrease compared to previous year.
Pamela Carroll, Senior Vice President, Immuno, Oncology, received $488K in 2018, which increases by 6% compared to 2017.